MoLEP-Co-creating a Mycobacterium leprae transmission interruption program for the Morogoro region, Tanzania. [PDF]
Barth-Jaeggi T +11 more
europepmc +1 more source
Deficiências após a alta medicamentosa da hanseníase: prevalência e distribuição espacial [PDF]
Castro SS +24 more
core +1 more source
Optimizing treatment of lepromatous form of leprosy using ofloxacin on top of standard multi-drug therapy in National Referral Hospital, Jakarta, Indonesia. [PDF]
Priyanto MH +4 more
europepmc +1 more source
Global leprosy scenario: Eradication, elimination or control? [PDF]
Gupte M.
europepmc +1 more source
Challenges of the public health response to a rare case of non-autochthonous <i>Mycobacterium leprae</i>, Ireland, 2024. [PDF]
Marshall R +9 more
europepmc +1 more source
Case of leprosy mimicking preseptal cellulitis: a diagnostic dilemma. [PDF]
Sarkar D, Chawla H, Singh P, Verma V.
europepmc +1 more source
Case Report: Recurrent Type 2 Leprosy Reaction Associated with Multiple Nerve Function Impairments Refractory to Steroids: A Therapeutic Challenge. [PDF]
Khurana A +4 more
europepmc +1 more source
Multibacillary leprosy with an incubation period exceeding 50 years. [PDF]
Taggart M, Kelly A, Stell R, Chu E.
europepmc +1 more source
Avermectins, New Family of Potent Anthelmintic Agents: Producing Organism and Fermentation
R. W. Burg +14 more
semanticscholar +1 more source

